Back to Journals » Drug Design, Development and Therapy » Volume 5
Corrigendum
Authors Paller CJ, Antonarakis E
Published 21 March 2011 Volume 2011:5 Pages 183—184
Paller CJ, Antonarakis ES. Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.
Drug Design, Development and Therapy. 2011;5:117–124.
The drug Jevtana was incorrectly named Jentava in Table 4.
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.